Fortune Meditech (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 3.97 M
as on 06-07-2024
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 M
as on 06-07-2024
- Revenue 8.66%
(FY 2023)
- Profit 48.32%
(FY 2023)
- Ebitda 711.21%
(FY 2023)
- Net Worth 4.81%
(FY 2023)
- Total Assets -3.83%
(FY 2023)
About Fortune Meditech (India)
The Corporate was formerly known as Quick Teknologies (India) Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.97 M.
The company currently has active open charges totaling ₹8.00 M.
Vivek Bhanot and Rajesh Kumar serve as directors at the Company.
- CIN/LLPIN
U72900DL2000PTC105143
- Company No.
105143
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Fortune Meditech (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Kumar  | Director | 06-Aug-2004 | Current |
| Vivek Bhanot | Director | 06-Aug-2004 | Current |
Financial Performance of Fortune Meditech (India).
Fortune Meditech (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.66% increase. The company also saw a substantial improvement in profitability, with a 48.32% increase in profit. The company's net worth moved up by a moderate rise of 4.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fortune Meditech (India)?
In 2023, Fortune Meditech (India) had a promoter holding of 42.21% and a public holding of 57.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Promis Medical Systems (India) Private LimitedActive 20 years 10 monthsVivek Bhanot is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 22 Oct 2008 | ₹8.00 M | Open |
How Many Employees Work at Fortune Meditech (India)?
Unlock and access historical data on people associated with Fortune Meditech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fortune Meditech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortune Meditech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
